Hepatocellular carcinoma (HCC) is a prevalent malignancy characterized by complex
heterogeneity and drug resistance. Resistance to ferroptosis is closely related to the …

Abstract Background & aims Metallothionein-3 (hMT3) is a structurally unique member of the
metallothioneins family of low-mass cysteine-rich proteins. hMT3 has poorly characterized …

Recent advancements in genetic engineering have made it possible to modify Natural Killer
(NK) cells to enhance their ability to fight against various cancers, including solid tumors …

Simple Summary In this study, we investigated the potential of TLR4 to improve the
treatment of hepatocellular carcinoma (HCC). HCC is a serious health concern worldwide …

Tumor-associated autoantibodies (TAAbs) have demonstrated potential as biomarkers for
cancer detection. However, the understanding of their role in hepatocellular carcinoma …

Background: Although immune microenvironment-related chemokines, extracellular matrix
(ECM), and intrahepatic immune cells are reported to be highly involved in hepatitis B virus …

Background Colorectal cancer (CRC) is a significant public health issue, ranking as one of
the predominant cancer types globally in terms of incidence. Intriguingly, Arenobufagin …

Hepatocellular carcinoma (HCC), the sixth most common cancer worldwide, is associated
with a high degree of malignancy and poor prognosis. Patients with early HCC may benefit …

Lenvatinib (LVN) is a potentially effective multiple-targeted receptor tyrosine kinase inhibitor
approved for treating hepatocellular carcinoma, metastatic renal cell carcinoma and thyroid …

Simple Summary The microenvironment of hepatocellular carcinoma is a really complex
milieu, containing a wide variety of cells with specific tasks, belonging to both the …